The Race for the Coronavirus Cure
There are currently 35 organizations around the world working feverishly day and night to become the first to discover a Coronavirus vaccine. This vaccine would be one of the most globally heralded scientific achievements in human history.
Currently, there are no known treatments or vaccines for the virus. For governments around the world whose main job it is to ensure the safety of their citizens, finding a cure is of paramount importance.
The first testing for the vaccine has been accomplished by the Boston biotechnology firm Moderna. “I don’t think proving this in an animal model is on the critical path to getting this to a clinical trial,” said Tal Zaks, Moderna's chief medical officer.
Clearly, the same safeguards are not being followed in this epic scientific rush.
Instead of the usual 15-20 year study that would normally take place before a vaccine is released plus animal trials, Moderna and 34 others are being fast tracked. Previous safeguards are being ignored.
Who knows what adverse effects of the vaccine could exist?
Moderna's trial will be funded by the National Institute of Health. Working so closely with the government will definitely expedite the chances of approval if can show efficacy.
A vaccine against the avian Coronavirus Infections Bronchitis Virus already exists at the MIGAL institute in Israel. Their researchers have been working 24/7 to adapting the vaccine for humans.
Migal researcher Dr. Chen Katz told the Jerusalem Post, “All we need to do is adjust the system to the new sequence. We are in the middle of this process, and hopefully in a few weeks we will have the vaccine in our hands. Yes, in a few weeks, if it all works, we would have a vaccine to prevent coronavirus,”
The safety approval process in Israel; which has miraculously not had a fatality among its 200+ Coronavirus cases, would be 90 days after Migal submitted their application.
However, in the United States, the approval process will be much slower. Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases said, “you’re talking about a year to a year and a half, before any vaccine could be ready for widespread use."